Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Serina Therapeutics, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Serina Therapeutics appointed Dr. Srini Tenjarla as Chief Technology Officer, promoting him from Senior Vice President of CMC and Formulation, while also increasing CEO Steve Ledger's salary to $500,000. This leadership restructuring signals the company's focus on strengthening operational and strategic capabilities.
Key Takeaways
Dr. Srini Tenjarla promoted to Chief Technology Officer effective April 20, 2026, from his previous role as SVP of CMC and Formulation since July 2024
Dr. Tenjarla's new annual base salary is $425,000 following his promotion
2 more takeaways